LKT Labs

Biochemicals for Life Science Research

Medroxyprogesterone 17-Acetate

Medroxyprogesterone 17-Acetate

Product ID M1613
Cas No. 71-58-9
Purity ≥99%
Product Unit SizeCostQuantityStock
500 mg $77.80 In stock
1 g $129.80 In stock
5 g $498.50 In stock
Bulk Quote

Quicklinks

Description

Medroxyprogesterone 17-acetate (MPA) is a synthetic steroid that activates progesterone, androgen, and glucocorticoid receptors. MPA exhibits contraceptive and anticancer activities and is also used in hormone replacement therapy, endometriosis, and dysmenorrhea. MPA decreases levels of adrenocorticotropic hormone (ACTH), cortisol, and other hormones; it also inhibits 3α-hydroxysteroid dehydrogenase. This compound is used clinically to treat breast cancer and inhibits the proliferation and growth of breast cancer cells and tumors in various models.

Product Info

Cas No.

71-58-9
Purity

≥99%
Formula

C24H34O4
Formula Wt.

386.52
Chemical Name

17-α-Acetoxy-6α-methylprogesterone
IUPAC Name

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9, 11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
Synonym

MAP, Clinovir, Depo-Provera, Farlutal, Nidaxin, Oragest, Prodasone, Provera, Veramix
Melting Point

207-209°C
Solubility

Soluble in chloroform or acetone.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

M1613 MSDS PDF
Info Sheet

M1613 Info Sheet PDF

References

Schindler AE, Campagnoli C, Druckmann R, et al. Classification and pharmacology of progestins. Maturitas. 2008 Sep-Oct;61(1-2):171-80. PMID: 19434889.

Meyer L, Venard C, Schaeffer V, et al. The biological activity of 3alpha-hydroxysteroid oxido-reductase in the spinal cord regulates thermal and mechanical pain thresholds after sciatic nerve injury. Neurobiol Dis. 2008 Apr;30(1):30-41. PMID: 18291663.

Poulin R, Baker D, Poirier D, et al. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res Treat. 1989 Mar;13(2):161-72. PMID: 2525057.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • H3272

    His Tag

    Six-histidine peptide used for affinity column ...

    ≥98%
  • A4675

    Alternariol

    Mycotoxin produced by Alternaria; topoisomerase...

    ≥98%
  • C4557

    Clofibrate

    Fibrate; PPARα agonist.

    ≥99%
  • C3477

    Citalopram Hydrobromide

    SERT inhibitor.

    ≥98%
  • G0179

    Gastrin-1, rat

    Endogenous peptide hormone; CCK2 agonist, indir...

    ≥95%
  • S6131

    N,N-Dimethyl-Sphingosine

    PP2A activator, Sphk1 and PKC inhibitor.

    ≥98%
  • E7857

    Etofenamate

    NSAID; COX-1/2 and lipoxygenase inhibitor.

    ≥98%
  • M721002

    MSA-2

    STING agonist

    ≥98%
  • B1746

    Belinostat

    HDAC inhibitor.

    ≥98%
  • N1982

    Neuromedin U, rat

    Endogenous neuropeptide, involved in energy hom...

    ≥95%
  • T3584

    Tivantinib

    MET and GSK-3α/β inhibitor.

    ≥98%
  • B5561

    B-type Natriuretic Peptide (1-32), human

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥97%
  • B465806

    BLU-667

    RET inhibitor.

    ≥98%
  • D3201

    Diallyl Sulfide

    Organosulfur found in garlic.

    ≥98%
  • T6932

    Triflumizole

    Imidazole; PPARγ agonist, RORγ inverse agonis...

    ≥95%
  • U5233

    Universal Tetanus Toxin Epitope P2 (830-844)

    Peptide, tetanus toxin epitope.

    ≥95%
  • C4517

    Clenbuterol Hydrochloride

    β2-adrenergic agonist.

    ≥98%
  • Y4800

    YM-155

    Survivin inhibitor.

    ≥99%
  • G8225

    Guggulsterone

    Steroid found in myrrh; FXR antagonist.

    ≥98%
  • G733400

    GSK-2578215A

    Selective inhibitor of LRRK2.

    ≥98%